Gold Club entrance

San Francisco, CA (PRWEB) May 19, 2012

Gold Club, the top choice venue in San Francisco adult entertainment, is introducing a new weekly industry event—In the Mix. Each and every Sunday, In the Mix will include free admission, half-off bottle service and other drink specials, along with fresh new sounds provided by guest DJs from around the country. Also, hospitality industry professionals will receive VIP treatment. This exhilarating new affair is kicking off at the San Francisco strip club on Sunday, June 3 from 9 pm to 2 am with special guest DJ Mick Boogie.

“We are thrilled at the prospect of this event,” said Axel Sang, a representative of Gold Club. “We are providing a unique and fun atmosphere for our guests to enjoy original music, good food and drinks, as well as have an opportunity to network within the hospitality industry.”

Veteran jockey DJ Mick Boogie is on deck for the event opener. Guests can expect a little bit of everything from his set, with tunes ranging from 80s hits, rock and soul to disco, house electro and his popular hip-hop mash-ups. Mick Boogie is an in-demand DJ from New York City, slated as the leader of ceremonies for past events hosted by the likes of Jay-Z, Lebron James, Will Smith, Serena Williams and Anja Rubik.

In addition to gazing at gorgeous eye candy and enjoying authentic, rare cuts by out-of-town talent, this is also a weekly networking event for hospitality industry professionals on all levels. Guests are encouraged to bring company badges, business cards, paycheck stubs—whatever works, to present to Gold Club staff for exclusive VIP treatment. These special guests are provided with VIP access and exclusive food and drink specials.

With no cover charge, half-off bottles, beautiful ladies and a chance to mix and mingle with industry professionals from across the Bay Area, guests can expect an original, sophisticated, yet budget-friendly experience.

For more information about the Gold Club’s In the Mix weekly event or to make reservations, call the club at (415) 536-0300, visit GoldClubSF.com, or come by the club, located at 650 Howard Street in downtown San Francisco—across the street from Moscone Center.

Gold Club’s team encourages adults to like them on Facebook at facebook.com/goldclubsf, follow them on Twitter at @GoldClubSF, check out their video channel on YouTube at youtube.com/user/goldclubsanfrancisco, and read their reviews by Yelp reviewers at yelp.com/biz/gold-club-san-francisco.

About the Gold Club

The Gold Club, winner of SF Weekly’s Best Strip Club honor 2 years running in 2011 and 2012, is a world-class gentlemen’s club conveniently located in the heart of downtown San Francisco. With over 200 of the most erotic and exotic entertainers, a fine dining restaurant, five fully stocked bars and VIP skybox service, the Gold Club is San Francisco’s premier erotic entertainment venue.

The Gold Club recognizes the value of customer satisfaction and consistently succeeds in supplying a highly entertaining and sensual experience to all guests. Outstanding special features include concierge services, champagne rooms, bottle service tables and booths, free secure WiFi access, limo services, and valet parking. The Gold Club is a popular destination for San Francisco bachelor parties, business meetings, or just a fun time out with friends in a comfortable, upscale environment.

Attachments

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Boston, MA (PRWEB) May 17, 2012

Leading global public health experts and NGO and business leaders will convene for two days in Lexington, Massachusetts to identify innovative solutions for improving the treatment of multi-drug resistant tuberculosis (MDR-TB), which kills more than 150,000 people each year.

The goal of the Innovation Summit, jointly organized by The Lilly MDR-TB Partnership and the Stop TB Partnership, and facilitated by Innosight, is to find solutions for identified barriers to treating the disease.

MDR-TB is a form of tuberculosis that is resistant to the drugs most commonly used to treat the disease. It afflicts more than 500,000 people worldwide with some 80 percent of cases occurring in India, China, Russia, and South Africa.

Due to drug resistance, MDR-TB must be treated with second-line drugs (SLD). Because of a range of challenges, however, fewer than 20,000 patients are treated each year with quality-assured SLD drugs. The summit will use Innosight’s solutions development process to focus on 14 critical SLD supply chain barriers from the viewpoint of different stakeholders.

In attendance will be more than 35 experts from a variety of organizations dedicated to treating and eradicating MDR-TB, including the World Health Organization, the Centers for Disease Control, Partners in Health, the Global Health Delivery Project at Harvard, USAID, Wal-Mart, IDA Foundation, Eli Lilly and Company, Massachusetts Institute of Technology, and others.

Said Tracy Sims, Vice President, Lilly Foundation, “high-quality second-line drugs for MDR-TB exist, but a variety of barriers cripple the supply chain and result in an unacceptably high number of patients who go untreated. In bringing some of the most talented and committed experts in MDR-TB together at this summit, we believe we can make great progress in developing actionable solutions to break down these barriers, improve access to treatment, and save lives.”

Following the summit, participants will seek to identify methods to test and implement the identified solutions.

About Innosight

Innosight is an innovation consulting firm with offices in Boston, Singapore, and India. It works with companies to develop growth strategies, discover new, high-growth markets, build innovation capabilities, and create disruptive new products, businesses, and services. Its comprehensive, integrated approach converts the quest for innovation and growth into a predictable and reliable process. For more information, visit http://www.innosight.com.

Attachments

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

New York, New York (PRWEB) May 15, 2012

Bernstein Liebhard LLP, a nationwide law firm representing clients with metal-on-metal hip implants, is pleased to report that on April 25, 2012, the European Parliament’s Environment and Public Health Committee unanimously passed a resolution seeking to create a medical implant registry, which will allow health officials to implement measures to help track failure rates of dangerous medical devices, such as metal-on-metal hip implants.* In addition to creating a medical implant registry, the resolution also contained recommendations to keep patients safe from dangerous medical devices, such as: vigilant monitoring, product traceability, and establishing a pre-market authorization system. The case of defective metal-on-metal hip implants and other dangerous medical devices “have shown a failure of the current system of certification of compliance . . . as well as of the controls of the notified bodies and their surveillance by national competent authorities,” the Members of European Parliament (“MEPs”) said.

“Similar criticisms can be made of the U.S. system for regulatory approval of certain medical devices,” said Bernstein Liebhard LLP partner Felecia L. Stern. According to Stern, “Patients with implants should be entitled to information concerning the performance record of those implants. If there is a significant failure rate, as there was with the DePuy ASR metal-on-metal hip implants, that information must be made public—in real time. If this country implemented a medical implant registry it would go a long way in helping save patients from the disastrous effects of defective and dangerous medical devices.”

European Parliament Calls For Strong Measures To Avert Future Metal-On-Metal Hip Implant Disasters

According to the resolution, European Union legislation to monitor dangerous medical devices will be revised this year. MEPs hope to improve the transparency and raise the criteria for checks, inspection, market surveillance and information sharing of adverse effects from dangerous medical devices. One aspect of the resolution aims to strengthen traceability and coordination of devices such as metal-on-metal hip implants, which will make it easier for patients and health care professionals to report adverse events. The resolution calls for a pre-market authorization system for dangerous medical devices to help patients be aware of the devices’ risks. The system will allow information to be exchanged so that it will be easier for patients to be notified of defects; it also includes a protocol for patients to obtain compensation if they are injured. Finally, the resolution suggests creating a single European database to bring together information about medical devices on the market, including device registration, surveillance, clinical investigations, notified bodies and EC certificates issued.

Dangerous Medical Devices Such as Metal-On-Metal Hip Implants Lead to Litigation

Individuals who suffered from defective devices such as metal-on-metal hip implants are filing lawsuits against metal hip manufacturers to seek compensation for their injuries. The lawyers at Bernstein Liebhard LLP are actively involved in numerous litigations concerning metal-on-metal hip implants, including: In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation (“MDL No. 2197”), which is currently underway in the U.S. District Court for the Northern District of Ohio and In re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation (“MDL No. 2244”), which is currently underway in the U.S. District Court for the Northern District of Texas. The firm is also investigating cases concerning another metal-on-metal hip implant manufactured by Wright Medical Technology, Inc. Lawsuits involving this hip replacement were recently consolidated in In re: Wright Medical Technology, Inc., Conserve Hip Implant Products Liability Litigation (“MDL No. 2329”), which is now pending in the U.S. District Court for the Northern District of Georgia.

Those who have experienced complications from metal-on-metal hip implants may be entitled to compensation for medical expenses, pain and suffering, lost wages and other injuries. Learn more about filing a metal-on-metal hip replacement lawsuit by visiting our website, http://www.consumerinjurylawyers.com, or by watching this video.

*europarl.europa.eu/news/en/pressroom/content/20120423IPR43732/html/PIP-breast-implants-learn-the-lessons-of-this-fraud

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past nine consecutive years. Only two firms in the country have been selected for the Hot List nine years in a row.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

(877) 779-1414

ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Felecia L. Stern, Esq.

Bernstein Liebhard LLP

info(at)consumerinjurylawyers.com

http://www.consumerinjurylawyers.com

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Big4

(PRWEB) May 12, 2012

Big4.com, the premier social networking forum for professionals and alumni of Accenture, Andersen, BearingPoint, Capgemini, Deloitte, Ernst & Young, KPMG and PricewaterhouseCoopers, PwC reports on a new contract extension for Accenture with the United Kingdom Department of Health.

Big4.com reports the company has been awarded a one-year extension to continue providing Picture Archiving and Communications Systems (PACS) to National Health Service Trusts (NHS) in the North East and East of England/East Midlands. They will continue to manage the Central Data Store, which provides Trusts with a centrally-hosted, long-term image archive, until June 2016.

Matt Oakley leads Accenture’s Medical Images Practice in the U.K. & Ireland and he commented:

“PACS is an excellent example of how technology is helping to improve patient care by providing clinicians with easy access to medical images and enabling them to make decisions more quickly,” he said. “Accenture provides a 24×7 managed service to enhance system stability and improve response time to resolving issues.”

Accenture’s PACS is a community-wide system used to electronically capture, view, store and distribute medical imaging (i.e. x-rays, MRIs) digitally. This technology has benefited more than 90 hospitals and helped to improve patient care.

About Big4.com

Big4.com is the accounting, tax, consulting and IT professions’ premier resource, and has been exclusively focused on Big Four firm professionals and alumni for 10 years, providing high quality content, connectivity and commerce. The Big Four Job Board offers fresh job opportunities – clients include the world’s leading companies. Big Four News covers key news, developments, events, survey results, press releases and appointments. The Big Four Blog provides opinion and insight on recent and key developments, news, happenings, management changes, regulations, acquisitions and capital market activities. Big4 Video is a professionally produced news covering key global developments in this space.

Big4.com has a strong presence on key social media platforms:

Youtube: Big4Video is a professionally produced weekly news magazine.

Twitter: twitter.com/big4 has 9,000 followers.

LinkedIn: The Big Four Alumni and Professionals group is the largest corporate and alumni group with 85,000+ members.

Facebook: The Big4 fan page has 5,500 fans at facebook.com/big4page.

Xing: The Big Four Alumni and Professionals group has 1,450+ members.    

Contact

Kristy Short

Big4.com

(734) 481-0186

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Pharmacology

Mannheim, Germany (PRWEB) May 10, 2012

ScienceIndex.com is a health social network established in 1998 to index the very latest news, headlines, references and resources from science journals, books and websites worldwide. The site covers news in all fields of biology, business, chemistry, engineering, geography, health, mathematics and society. In the field of Health Sciences, the site has now included the two new categories Pharmacology and Psychiatry. While the Pharmacology category covers composition, uses, and effects of drugs, the Psychiatry category covers the diagnosis, treatment, and prevention of mental and emotional disorders.

ScienceIndex.com’s Health Category covers the effects of disease and medical treatment on the overall condition of organisms. Its eighteen subsections include Audiology, Dentistry, Dermatology, Endocrinology, Gastroenterology, Healthcare, Immunology, Medicine, Neurology, Nutrition, Oncology, Pathology, Pharmacology, Psychiatry, Psychology, Radiology, Rheumatology, and Surgery. Users can receive alerts if new content has been posted in this category by subscribing to ScienceIndex.com’s Health RSS feed.

ScienceIndex.com’s Pharmacology category covers composition, uses, and effects of drugs. It currently contains 29,615 articles partly derived from 154 scientific journals. The latest articles in this category are also available through an Pharmacology Sciences RSS feed. One of the latest additions assessed the in vivo antitumor efficacy of a polypeptide-based poly-L-glutamic acid-gemcitabine conjugate (PG-G) in tumor-bearing mice. The antitumor effects of PG-G were superior to those of unconjugated gemcitabine in both single and four-consecutive dosing studies. The authors’ study demonstrates that the PG-G formulation shows a significant antitumor activity in terms of tumor growth inhibition and shrinkage and that the PG-G dose regimen need to be optimized to minimize side effects and render it a potential anticancer therapeutic. Another recently published article in this category reviews prescribing errors in hospital practice. Errors have been reported in handwritten descriptions of almost 15 percent and with electronic prescribing of up to 8 percent of orders.

ScienceIndex.com’s Psychiatry category covers the diagnosis, treatment, and prevention of mental and emotional disorders. It currently contains 7,772 articles partly derived from 63 scientific journals. The latest articles in this category are also available through a Psychiatry Sciences RSS feed. One recently included article in this category studies the effect of purpose in life on the relation between Alzheimer disease (AD). The authors tested the hypothesis that purpose in life reduces the deleterious effects of AD pathologic changes on cognition in advanced age. Their results indicate that higher levels of purpose in life reduce the deleterious effects of AD pathologic changes on cognition in advanced age. Another recently published article covers polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia. While polypharmacy is widely used in the treatment of schizophrenia, it is believed to have major adverse effects on the well-being of patients. The authors of this study linked national databases of mortality and medication prescriptions among a complete nationwide cohort of 2,588 patients hospitalized in Finland with a diagnosis of schizophrenia between 2000 and 2007. Benzodiazepine use was associated with a substantial increase in mortality, and this was attributable to suicidal deaths and to nonsuicidal deaths. In contrast, the use of an antidepressant or several concomitant antipsychotics was not associated with an increase in mortality.

ScienceIndex.com currently contains over 1.46 million stories distributed among 75 categories. 76,341 users monitor nearly 8,400 journals covering the broad spectrum of sciences. Since new science content is discovered in real-time, the delay between original publication and appearance at ScienceIndex.com is no more than two days. ScienceIndex.com provides an advanced search feature which suggests up to ten closely related articles for a search and every selected story.

Attachments

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

San Francisco, California (PRWEB) May 08, 2012

Motion To Dismiss Cancer, a team formed to raise money for the Leukemia & Lymphoma Society announces the third round of the “2012 Venture Capital Master’s Lunch Series” auction where anyone with the highest bid can get face time to pitch, discuss and seek advice from some of Silicon Valley’s most influential venture capitalists, founders, and executives. The auction begins May 7th and runs through May 17, 2012. Bidding here now: http://myworld.ebay.com/celebrityexperienceforlls

The third round includes: Greylock, Y Combinator, Draper Fisher Jurvetson, New Enterprise Associates, North Bridge Venture Partners and Bessemer Venture Partners, 23andMe, and RockHealth.

Greylock Partners, including Ali Rosenthal, an Executive in Residence, Josh Elman, a Principal, and Tom Frangione, COO, who’ve helped drive product and growth at companies like Facebook, Twitter, and LinkedIn. Greylock partners with entrepreneurs that want to build disruptive consumer and enterprise software companies. Greylock has invested in companies such as Facebook, Pandora, LinkedIn, Palo Alto Networks, Workday and many others.

Y Combinator, consisting of Partners Harj Taggar, Garry Tan and Sam Altman is a seed-stage startup funding firm founded in 2005 to provide seed money, advice and connections at two 3-month programs per year. Because of the organization’s flexible approach to investing, Wired Magazine has called Y Combinator a “boot camp for startups” and “the most prestigious program for budding digital entrepreneurs.”

Draper Fisher Jurvetson’s Managing Director, Josh Stein, sits on the board of Box.net, Chartbeat, Eventful, Fynanz, GoodGuide, Polaris Wireless, Redfin, SugarCRM, and ViVOTech. Josh is also actively involved with the firm’s investments in Glam Media, Opscode, Tremor Media, and Yammer. Josh Stein’s previous investments include iList (acquired by IGN/News Corp) and Yardbarker (acquired by Fox Sports Interactive).

New Enterprise Associates’ partner Patrick Chung co-heads NEA’s consumer and seed-stage investing practices and is a founding partner of NEA and Harvard’s Experiment Fund (http://www.xfund.com). He is a director of 23andMe, Euclid, GoodGuide, Loopt, Lytro, Mapply, Pulse, and is actively involved with Fantasy Shopper, Fanhattan, GrubWithUs, IFTTT, RockHealth, Subtext and Tivli.

North Bridge Venture Partners’ Jonathan Heiliger, General Partner, joined the firm in 2012 in its California office, expanding the firm’s West Coast presence, and focuses on seed and venture investments in communications and infrastructure, software, and digital media sectors. Jonathan is the former Vice President of Technical Operations at Facebook, where he oversaw global infrastructure and internal technology systems.

Bessemer Venture Partners’ Byron Deeter, Partner, and Ethan Kurzweil, Vice President, help manage more than $ 4 billion of venture capital invested in over 130 companies around the world, including LinkedIn, Pinterest, Skype, Twilio and Box, Crowdflower, Adap.TV Playdom, Zoosk, Reputation.com, and Piazza to name a few. Joining Byron and Ethan is Sarah Tavel of Bessemer Venture Partners portfolio company, Pinterest.

23andMe’s Ashley Dombkowski, PhD, and Chief Business Officer, leads a personal genetics company, which is dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools.

RockHealth’s Founder and CEO, Halle Tecco founded the first startup accelerator devoted exclusively to health companies. Tecco recognized the need and potential for startups in the digital health space while working at Apple’s App Store covering the health and medical vertical.

The Annual Venture Capitalist/Founder’s Auction is a high-demand item on eBay. Every week, another round of venture capitalists and founders’ auctions will be listed on eBay. The next round of auctions will include luminaries such as Sean Parker, BandPage (Founder & CEO J Sider), Votizen (Co-founder Jason Putorti) and many more.

For more information about the 2012 Venture Capital Master’s Lunch Series visit: http://myworld.ebay.com/celebrityexperienceforlls or contact Christina Resasco at (415) 724-7882 or at christina (at) causevault (dot) com.

For more information about Team Motion to Dismiss Cancer’s efforts to raise money for LLS please visit http://www.M2DCancer.org

Attachments

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

London, UK (PRWEB UK) 26 April 2012

HealthExpress is one of the leading providers of online healthcare in the UK, offering a secure and verified method of ordering prescription medications discreetly and conveniently online. A range of treatment options for a number of lifestyle and medical conditions are available on the site, including for high cholesterol. Comprehensive information relating to the relevant condition, such as causes and symptoms, is also provided to all visitors and patients. The high cholesterol treatment Simvastatin has been available on HealthExpress for some time, but nine additional treatment options have been added this month to offer patients greater variety of choice.

High cholesterol is a serious condition because it has the potential to lead to the development of life-threatening cardiovascular problems such as atherosclerosis and coronary heart disease. The term “high cholesterol” refers specifically to high levels of the harmful low density lipoprotein (LDL cholesterol). The other form of cholesterol, high density lipoprotein, is known as “good” cholesterol. When someone receives a high cholesterol diagnosis, they are usually advised to undertake a number of lifestyle changes, such as those relating to diet and exercise, in an attempt to reduce cholesterol naturally.

For some people, these lifestyle changes will not be sufficient and high cholesterol treatment will be recommended in the form of statins. Statins are highly effective prescription medications that are able to lower harmful cholesterol levels. There are a number of different types of statin available, both as branded and generic medications, of which HealthExpress offers ten: Crestor, Fluvastatin, Lipitor, Pravastatin, Atorvastatin, Lescol, Lipostat, Rosuvastatin, Zocor and Simvastatin. To ensure the safety of their patients, HealthExpress only allows those who have been diagnosed with high cholesterol and advised a specific treatment by a doctor to order the medication online.

HealthExpress Company Information

HealthExpress is an online clinic specialising in providing treatment, support and advice for common embarrassing medical conditions and lifestyle problems. Launched in 2002, they provide their patients with a discreet, confidential and secure way to order prescription medication online by completing a free online consultation with a registered doctor.

For more details, visit the website at http://www.healthexpress.co.uk or contact HealthExpress on 020 7084 7594 or via email.

HealthExpress is a brand name of Hexpress Healthcare Ltd, PO Box 344, Mont Crevelt House, Bulwer Avenue, St. Sampson, Guernsey GY1 3US. Phone: 020 7084 7060.

Attachments

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

New York, NY (PRWEB) May 05, 2012

Journalists representing Self Magazine, Health.com, The Commercial Appeal, Pittsburgh Tribune, The Dr. Oz Show, and ABC’s World News with Diane Sawyer are among winners receiving top honors in the 2012 American Society for Aesthetic Plastic Surgery (ASAPS) Journalistic Achievement Awards. Selected from over 150 entries nationwide, this year’s winners will be presented a certificate of merit and a downloadable video presentation honoring the winners will be featured during the Aesthetic Society’s Annual Meeting in Vancouver and available for public viewing on surgery.org after the Meeting. ASAPS, founded in 1967, is the leading national organization of board-certified plastic surgeons specializing in cosmetic surgery of the face and body.

“Each of the nominees has truly helped promote our Society’s mission of public education,” said Daniel C. Mills, MD, Chair of the Aesthetic Society’s Communications Commission and a plastic surgeon in Laguna Beach, CA. “These journalists have done an outstanding job reporting the latest trends, newest technologies, and the importance of patient safety in plastic surgery.”    

“This year, there were several nominated articles that highlighted the importance of finding a board-certified plastic surgeon,” said Aesthetic Society President, Jeffrey M. Kenkel, MD, a plastic surgeon from Dallas, Texas. “Many of these published pieces discussed medical tourism, the different kinds of injectables, the most popular surgical trends and patient safety. We applaud all these journalists for their excellent coverage of the cosmetic surgery industry and for promoting the importance of patient safety.”

Each year, the American Society for Aesthetic Plastic Surgery honors journalists for their reporting on cosmetic plastic surgery. Entries are accepted in six categories: Television Feature, Television News, Newspaper, Magazine, Internet, and Patient Safety.

This year, first place in the Television News category goes to Julia Bain of ABC’s World News with Diane Sawyer for her piece “Plastic Surgery Rise for Baby Boomers”, which discussed the increase in adults over 65 years old turning to plastic surgery, and undergoing everything from facelifts to breast augmentations. The segment included an interview with Alan H. Gold, MD, Past-President of the Aesthetic Society and a plastic surgeon in Great Neck, NY.

The winner of the Feature News category goes to Associate Producer for The Dr. Oz Show, Christine Smith, for her excellent coverage of Suzanne Somers’ path to a controversial stem cell fat breast reconstruction after breast cancer. To maintain a balanced presentation, Christine also invited Peter Rubin, MD, Chief of Plastic Surgery and stem cell research at the University of Pittsburgh Medical Center, to deal with Somers’ claims about stem cells and clinical practices using stem cells that have not necessarily been backed by scientific evidence.

This year, Sabrina Rubin Erdely receives top recognition for her article “Wide Awake and Under the Knife” published in Self Magazine. This article is about a woman who traveled outside of the United States to have liposuction, breast augmentation and a tummy tuck performed under no anesthesia at a discounted price. Self magazine investigates the true price of ‘bargain’ cosmetic surgery and the importance of a board-certified plastic surgeon.

Barbara Bradley, from The Commercial Appeal, won first place in the Internet category for her article, “Mommy Makeover: Cosmetic Surgery is Gaining Popularity to Restore Pre-Pregnancy Looks.” This article discusses the increased demand and popularity of mothers seeking liposuction, tummy tucks, and breast augmentations to restore pre-pregnancy bodies.

First place in the Patient Safety category goes to Roxanne Patel Shepelavy of Health magazine, for her article, “Nip/Tuck Nightmare: The Dangerous New World of Cosmetic Surgery.” The piece investigates black market cosmetic procedures and the dangers of unqualified physicians performing cosmetic surgery.

Chris Ramirez, of the Pittsburgh Tribune Review takes top honor for his newspaper article, “Nip/Tuck Partners: More couples are getting plastic surgery together.” The piece discusses the popular new trend of couples getting plastic surgery together to improve their appearances to look and feel better as a pair.    

A panel of aesthetic plastic surgeons and communications professionals evaluated each entry for accuracy of information, balanced reporting, educational value, interest, originality, and journalistic style. Winners receive a personal certificate of merit and an awards presentation honoring the winners will be presented on the ASAPS website and accessible for download.

For more information on the Aesthetic Society’s Journalistic Achievement Awards, visit the Press Center on the Aesthetic Society web site at http://www.surgery.org.

###

Journalistic Achievement Awards Presentation

Saturday, May 5, 11:30 AM

About ASAPS

The American Society for Aesthetic Plastic Surgery (ASAPS), is recognized as the world’s leading organization devoted entirely to aesthetic plastic surgery and cosmetic medicine of the face and body. ASAPS is comprised of over 2,600 Plastic Surgeons; active members are certified by the American Board of Plastic Surgery (USA) or by the Royal College of Physicians and Surgeons of Canada and have extensive training in the complete spectrum of surgical and non-surgical aesthetic procedures. International active members are certified by equivalent boards of their respective countries. All members worldwide adhere to a strict Code of Ethics and must meet stringent membership requirements.

Website: http://www.surgery.org

Follow ASAPS on Twitter: http://www.twitter.com/ASAPS

Become a fan of ASAPS on Facebook: http://www.facebook.com/AestheticSociety

Become a member of Project Beauty: http://www.projectbeauty.com

Locate a plastic surgeon in your area: http://www.surgery.org/consumers/find-a-plastic-surgeon

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

New York, NY (PRWEB) April 23, 2012

Parker Waichman LLP, a national law firm dedicated to protecting the legal rights of people injured by defective drugs, warns that prolonged use of proton pump inhibitors (PPIs) has been associated with serious side effects, including bone fractures and hypomagnesaemia (low magnesium levels). This week, the U.K.’s Medicines and Healthcare Products Regulatory Agency (MRHA) warned patients and doctors there of the possible association between PPIs and either of these side effects. The U.S. Food & Drug Administration (FDA) issued a similar warning regarding hypomagnesaemia in March 2011. The FDA ordered the makers of prescription PPIs to add warnings to their labels regarding the risk of fractures in May 2010.

PPIs inhibitors work by reducing the amount of acid in the stomach, and are approved to treat conditions such as gastroesophageal reflux disease (GERD), stomach and small intestine ulcers, and inflammation of the esophagus. The drugs, which are available in prescription and over-the-counter versions, are sold under a number of brand names, including:

    Dexilant (dexlansoprazole)
    Nexium (esomeprazole magnesium)
    Prevacid (lansoprazole) and OTC Prevacid 24hr
    Prilosec (omeprazole) and Prilosec OTC
    Protonix (pantoprazole sodium)
    Vimovo (esomeprazole magnesium and naproxen)
    Zegerid (omeprazole and Sodium bicarbonate) and Zegerid OTC

This week, the MHRA warned that studies on a risk of fracture associated with PPIs suggest there may be a modest increase in the risk of hip, wrist, or spine fracture, especially if PPIs are used in high doses and over long durations (>1 year). The increased risk was observed mainly in elderly patients, and it is possible that other risk factors contribute to the increase in risk. According to the agency, two meta-analyses of studies suggest the risk of fracture is increased by 10–40% above baseline. The primary studies in these analyses have varied in the extent to which they have adjusted for other potential risk factors for fracture, and use of calcium or vitamin D, the MHRA said. [mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON149775]

In May 2010, the FDA announced new warnings would be added to the labels of prescription PPI after its review of several epidemiological studies found increased risk of fractures of the hip, wrist, and spine with PPI use. Some studies found that those at greatest risk for these fractures received high doses of PPI or used them for one year or more. The majority of the studies evaluated individuals 50 years of age or older and the increased risk of fracture primarily was observed in this age group, the FDA said.[fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm213206.htm]

According to another MHRA warning issued this week, a review of case reports described in the literature or reported to regulatory authorities in Europe suggests that PPIs may cause hypomagnesaemia. Some cases occurred after 3 months of PPI therapy, but most occurred after 1 year of treatment. Symptoms of hypomagnesaemia may begin insidiously and be overlooked. In most case reports, hypomagnesaemia improved after magnesium replacement and discontinuation of the PPI. [mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON149774]

Hypomagnesaemia occurs when there are low levels of magnesium in the blood. Common symptoms of the condition include:

    Abnormal eye movements
    Convulsions
    Fatigue
    Muscle spasms or cramps
    Muscle weakness
    Numbness

If untreated, hypomagnesaemia can lead to cardiac and/or respiratory arrest and death.

In a Drug Safety Communication issued in March 2011, the FDA announced that it had mandated that information about the potential risk of low magnesium be added to the WARNINGS AND PRECAUTIONS sections of the labels for all prescription PPIs. According to the agency, hypomagnesaemia has been reported in adult patients taking PPIs for at least three months, but most cases occurred after a year of treatment. Approximately one-quarter of these cases required discontinuation of PPI treatment in addition to magnesium supplementation. [fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm245275.htm]

Parker Waichman LLP offers free legal consultations to victims of PPI side effects. If you or a loved one sustained a fracture or suffered from hypomagnesaemia while taking a PPI, please contact their office by visiting the firm’s PPI Injury page at http://www.yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

For more information regarding PPI injury lawsuits and Parker Waichman LLP, please visit: http://www.yourlawyer.com or call 1-800-LAW-INFO (1-800-529-4636).

Contact:

Parker Waichman LLP

Herbert Waichman, Partner

(800) LAW-INFO

(800) 529-4636

http://www.yourlawyer.com

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

New York, NY (PRWEB) March 02, 2012

Dr. Bonnie Eaker Weil’s book “Make Up Don’t Break Up” is an antidote to the marital trend of sleeping in separate bedrooms. Dr. Bonnie has written in the past regarding this topic and has seen it reappear with a different viewpoint at (http://www.huffingtonpost.com/josey-vogels/couples-sleep-separately_b_1212775.html) According to the National Sleep Foundation, one in four American couples sleep in separate beds. By 2015, the National Homebuilders Association predicts 60 percent of custom-built homes will have two master suites. Read more: http://www.oprah.com/oprahshow/Straight-Talk-from-Dr-Phil/2 “This is a very unhealthy preference, especially when it is followed by the prediction by the National Association of Home Builders survey predicting that 60 percent of custom homes will be outfitted with dual master bedrooms by 2015. People know how to fall in love, but don’t understand the key elements to staying in love and connected. Sleeping together increases physical comfort and frequency of sex.” Dr. Bonnie Weil, known as the #1 Love Expert believes that physical closeness is the glue needed to keep couples together during conflict and rough times.

“Sleeping in separate bedrooms is a symptom of couples giving up on intimacy. Instead, couples need to have open and honest discussions about stress, fear, and bothersome habits,” offers Dr. Weil.

Sleeping separately can be a triggered by disorders such as restless leg syndrome, snoring, or sleep apnea. Other sleep interruptions can arise from one partner’s television habits, late night reading with the light on, or a Blackberry obsession. Maybe one partner is an early riser, and the other one is a night owl. Fussy kids, the flu, common colds, and pets vying for mattress real estate, can add up to a bedroom appearing more like a freeway during rush hour.

“Today’s worries, stress, overdrawn checking accounts, job instability and economic woes make a good night’s sleep a priority. But, separate bedroom might just be the nail in the marital coffin. It is critical that couples bring sizzle back into the relationship to create balance during difficult times,” explains Dr. Weil, author of Make Up Don’t Break Up and accompanying DVD titled Falling in Love and Staying in Love. Both products give specific guidelines to foster emotional and physical intimacy daily.

http://youtu.be/BjrqJoWX3K4

Text ADULTERY to 82257 to find out from Dr Bonnie if adultery may be looming in your relationship!

Interested in a few dating tips from internationally acclaimed relationship therapist Dr. Bonnie Eaker Weil?

Text DATINGTIPS to 82257 to receive Tips and Updates from Dr. Bonnie!

Dr. Bonnie Eaker Weil’s best-selling book, Adultery the Forgivable Sin is being re-released under a new distributor and making its appearance available in eBook format and print on Amazon.com (http://www.amazon.com/Adultery-Forgivable-Bonnie-Eaker-Weil/dp/1587768151/ref=sr_1_1?ie=UTF8&qid=1321019076&sr=8-1). Adultery the Forgivable Sin was also made into a Lifetime Original Movie starring Kate Jackson.

Dr. Bonnie Eaker Weil, PhD, is also author of the 2010 New York Times Reader’s Choice Award-winning book Make Up Don’t Break Up with accompanying DVD. Dr. Bonnie counsels couples, singles, and step families. She works with those considering breaking up, people who have committed adultery, and couples who want to strengthen their relationships damaged by resentment or unresolved anger, teaching people to “fight” to increase passion, bring back magic and restore the sizzle. Dr. Bonnie teaches Smart Heart Dialogue along with communication and connection tools, and counsel’s families and children.

Named the Best Local Therapist in 2011 by the US Commerce Association and known as “The Adultery Buster” and the “No. 1 Love Expert,” she is the best-selling author of other books like Can We Cure and Forgive Adultery?, How Not to (S)mother Your Man and Keep a Woman Happy, and Financial Infidelity: Making Money Sexy.

Dr. Bonnie was named by Psychology Today and NY Magazine as one of America’s Best Therapists and is presently featured and available now on the Discovery Health/Oprah Winfrey Network documentary titled “Unfaithful” and A&E on addictions. Find her on Good Morning America’s three-day series on NBC’s The Today Show, The Oprah Winfrey Show five times, and a four day series on Fox TV regarding dating. She appears frequently on ABC, Fox, CBS and NBC News, The View, 20/20, and CNN; and is often featured in USA Today and the New York Times. Visit Dr. Bonnie at http://www.DoctorBonnie.com

###

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.